Each filer's latest filing for 50127T109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Montanova Capital, LLC
13G/A
|
9.7% |
8/14/2026
Event 6/30/2026
|
||
| Montanova Capital, LLC | 9.7% | |||
| Averill Master Fund, Ltd. | 8.8% | |||
| Aaron Cowen | 9.7% | |||
| BlackRock, Inc. 13G/A | 8.9% |
10/27/2026
Event 9/30/2026
|
||
|
Biotechnology Value Fund L P
13G/A
|
7.5% |
11/16/2026
Event 9/30/2026
|
||
| Biotechnology Value Fund L P | 3.9% | |||
| BVF I GP LLC | 3.9% | |||
| Biotechnology Value Fund II LP | 2.9% | |||
| BVF II GP LLC | 2.9% | |||
| Biotechnology Value Trading Fund OS LP | 0.5% | |||
| BVF Partners OS Ltd. | 0.5% | |||
| BVF GP Holdings LLC | 6.9% | |||
| BVF Partners L P/IL | 7.5% | |||
| BVF Inc/IL | 7.5% | |||
| Lampert Mark N | 7.5% | |||
| State Street Corp 13G | 5.7% |
2/9/2026
Event 12/31/2025
|
||
| Vanguard Capital Management LLC 13G | 5.0% |
4/30/2026
Event 3/31/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (6) | ||||
|
RA Capital Management, L.P.
13G/A
|
4.9% |
5/15/2025
Event 3/31/2025
|
||
| RA Capital Management, L.P. | 4.9% | |||
| Peter Kolchinsky | 4.9% | |||
| Rajeev Shah | 4.9% | |||
| RA Capital Healthcare Fund, L.P. | 4.9% | |||
|
EcoR1 Capital, LLC
13G/A
|
4.8% |
8/14/2025
Event 6/30/2025
|
||
| EcoR1 Capital, LLC | 4.8% | |||
| Oleg Nodelman | 4.8% | |||
| EcoR1 Capital Fund Qualified, L.P. | 4.5% | |||
|
Armistice Capital, LLC
13G/A
|
4.2% |
5/15/2026
Event 3/31/2026
|
||
| Armistice Capital, LLC | 4.2% | |||
| Steven Boyd | 4.2% | |||
|
James E. Flynn
13G/A
|
0% |
2/13/2025
Event 12/31/2024
|
||
| Deerfield Mgmt, L.P. | 0% | |||
| Deerfield Management Company, L.P. | 0% | |||
| Deerfield Partners, L.P. | 0% | |||
| James E. Flynn | 0% | |||
|
Paradigm Biocapital Advisors LP
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| Paradigm BioCapital Advisors LP | 0% | |||
| Paradigm BioCapital Advisors GP LLC | 0% | |||
| Senai Asefaw, M.D. | 0% | |||
| Paradigm BioCapital International Fund Ltd. | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 234 | 88.8 M | $950M |
| 2026 Q2 | 222 | 86.9 M | $953M |
| 2026 Q1 | 222 | 84.4 M | $686M |
| 2025 Q4 | 217 | 85.4 M | $888M |
| 2025 Q3 | 200 | 83.9 M | $743M |
| 2025 Q2 | 184 | 82.1 M | $474M |
| 2025 Q1 | 185 | 80.4 M | $531M |
| 2024 Q4 | 187 | 78.8 M | $686M |
| 2024 Q3 | 181 | 82.4 M | $1.61B |
| 2024 Q2 | 177 | 80.5 M | $1.66B |
| 2024 Q1 | 170 | 80.8 M | $1.72B |
| 2023 Q4 | 142 | 78.8 M | $1.13B |
| 2023 Q3 | 135 | 75.3 M | $687M |
| 2023 Q2 | 151 | 75.1 M | $795M |
| 2023 Q1 | 143 | 72.5 M | $885M |
| 2022 Q4 | 143 | 70.1 M | $870M |
| 2022 Q3 | 150 | 71.6 M | $977M |
| 2022 Q2 | 152 | 68.7 M | $1.26B |
| 2022 Q1 | 154 | 66.7 M | $1.11B |
| 2021 Q4 | 154 | 64.1 M | $898M |
| 2021 Q3 | 157 | 66.7 M | $1.25B |
| 2021 Q2 | 174 | 67.6 M | $1.41B |
| 2021 Q1 | 174 | 68.6 M | $1.94B |
| 2020 Q4 | 206 | 65.1 M | $2.13B |
| 2020 Q3 | 163 | 53.8 M | $1.65B |
| 2020 Q2 | 135 | 52.4 M | $856M |
| 2020 Q1 | 120 | 39.8 M | $395M |
| 2019 Q4 | 129 | 39.0 M | $537M |
| 2019 Q3 | 117 | 40.2 M | $610M |
| 2019 Q2 | 123 | 38.7 M | $762M |
| 2019 Q1 | 105 | 32.0 M | $531M |
| 2018 Q4 | 100 | 32.4 M | $455M |
| 2018 Q3 | 119 | 30.3 M | $530M |
| 2018 Q2 | 109 | 29.8 M | $542M |
| 2018 Q1 | 98 | 23.6 M | $442M |
| 2017 Q4 | 76 | 19.5 M | $299M |
| 2017 Q3 | 66 | 19.4 M | $290M |
| 2017 Q2 | 44 | 10.8 M | $101M |
| 2017 Q1 | 35 | 10.3 M | $90.7M |
| 2016 Q4 | 30 | 9.88 M | $58.2M |
| 2016 Q3 | 28 | 9.75 M | $60.9M |
| 2016 Q2 | 25 | 9.32 M | $25.2M |
| 2016 Q1 | 20 | 10.2 M | $41.4M |
| 2015 Q4 | 14 | 10.2 M | $86.1M |